Mark Fridlyand - Director, Strategy & Corporate Development
Por um escritor misterioso
Descrição
Genentech: Mark Merchant Senior Director, Translational Oncology
Nuclear Odontogenic Ameloblast-Associated Protein (ODAM) Correlates with Melanoma Sentinel Lymph Node Metastasis
2022
img_003.jpg
PDF) Drug Target Identification in Triple Negative Breast Cancer Stem Cell Pathways: A Computational Study of Gene Regulatory Pathways Using Boolean Networks
Personalised medicine for the European Citizen
Mark Fridlyand - Director, Strategy & Corporate Development - Synonym
Alex Fridlyand email address & phone number Newlight Partners Partner contact information - RocketReach
Journal of Cellular Physiology, Cell Biology Journal
Edward Shenderovich - Co-founder & CEO at Synonym Biotechnologies
Bayesian metamodeling of complex biological systems across varying representations
Mark Fridlyand - Senior Database Developer - Intercontinental Exchange